Ruth Alon - Net Worth and Insider Trading

Ruth Alon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ruth Alon owns 5 companies in total, including Anchiano Therapeutics Ltd (CMMB) , Chemomab Therapeutics Ltd (CMMB) , and Moringa Acquisition Corp (MACAU) among others .

Click here to see the complete history of Ruth Alon’s form 4 insider trades.

Insider Ownership Summary of Ruth Alon

Ticker	Comapny	Transaction Date	Type of Owner
CMMB	Anchiano Therapeutics Ltd	2020-01-01	director
CMMB	Chemomab Therapeutics Ltd	2020-01-01	director
MACAU	Moringa Acquisition Corp	2021-02-16	director
		2021-02-16	director
		2023-01-01	director

Ruth Alon Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ruth Alon Ownership Network

Ownership Network List of Ruth Alon

No Data

Ownership Network Relation of Ruth Alon

Ruth Alon Owned Company Details

What does Anchiano Therapeutics Ltd do?

Who are the key executives at Anchiano Therapeutics Ltd?

Ruth Alon is the director of Anchiano Therapeutics Ltd. Other key executives at Anchiano Therapeutics Ltd include Chief Financial Officer Stephen J. Dipalma , other: Affiliate of 10% Owner Len Blavatnik , and 10 percent owner Access Industries Holdings Llc .

Anchiano Therapeutics Ltd (CMMB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Anchiano Therapeutics Ltd (CMMB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anchiano Therapeutics Ltd (CMMB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Anchiano Therapeutics Ltd (CMMB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Anchiano Therapeutics Ltd Insider Transactions

No Available Data

What does Chemomab Therapeutics Ltd do?

Who are the key executives at Chemomab Therapeutics Ltd?

Ruth Alon is the director of Chemomab Therapeutics Ltd. Other key executives at Chemomab Therapeutics Ltd include 10 percent owner Orbimed Israel Biofund Gp Limited Partnership , director & 10 percent owner & Chief Executive Officer George Adi Mor , and Chief Medical Officer Matthew Bejosa Frankel .

Chemomab Therapeutics Ltd (CMMB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Chemomab Therapeutics Ltd (CMMB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Chemomab Therapeutics Ltd (CMMB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Chemomab Therapeutics Ltd (CMMB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Chemomab Therapeutics Ltd Insider Transactions

No Available Data

What does Moringa Acquisition Corp do?

Who are the key executives at Moringa Acquisition Corp?

Ruth Alon is the director of Moringa Acquisition Corp. Other key executives at Moringa Acquisition Corp include 10 percent owner Hudson Bay Capital Management Lp , 10 percent owner Sander Gerber , and Chief Financial Officer Gil Maman .

Moringa Acquisition Corp (MACAU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Moringa Acquisition Corp (MACAU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Moringa Acquisition Corp (MACAU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Moringa Acquisition Corp (MACAU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Moringa Acquisition Corp Insider Transactions

No Available Data

What does Moringa Acquisition Corp do?

Who are the key executives at Moringa Acquisition Corp?

Ruth Alon is the director of Moringa Acquisition Corp. Other key executives at Moringa Acquisition Corp include Chief Financial Officer Gil Maman , director & 10 percent owner & Chairman and CEO Ilan Levin , and 10 percent owner Moringa Sponsor Us L.p. .

Moringa Acquisition Corp (MACA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Moringa Acquisition Corp (MACA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Moringa Acquisition Corp (MACA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Moringa Acquisition Corp (MACA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Moringa Acquisition Corp Insider Transactions

No Available Data

What does Vascular Biogenics Ltd do?

Who are the key executives at Vascular Biogenics Ltd?

Ruth Alon is the director of Vascular Biogenics Ltd. Other key executives at Vascular Biogenics Ltd include Chief Financial Officer Scott Alan Mcpherson , 10 percent owner Builders Vc Fund I, L.p. , and 10 percent owner Builders Vc Entrepreneurs Fund I, L.p. .

Vascular Biogenics Ltd (VBLT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Vascular Biogenics Ltd (VBLT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vascular Biogenics Ltd (VBLT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Vascular Biogenics Ltd (VBLT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vascular Biogenics Ltd Insider Transactions

No Available Data

Ruth Alon Mailing Address

Above is the net worth, insider trading, and ownership report for Ruth Alon. You might contact Ruth Alon via mailing address: 1/3 High-tech Village, Givat Ram, P.o. Box 39264, Jerusalem L3 9139102.

Discussions on Ruth Alon

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.